Apixaban to Prevent Venous Thromboembolism in Patients with Cancer
Carrier M, AVERT Investigators.
KEYWORDS
direct oral anticoagulant; thromboprophylaxis; cancer patients
BACKGROUND - Patients with active cancer have an increased risk of venous thromboembolism, which results in substantial morbidity, mortality, and health care expenditures. The Khorana score (range, 0 to 6, with higher scores indicating a higher risk of venous thromboembolism) has been validated to identify patients with cancer at elevated risk for this complication and may help select those who could benefit from thromboprophylaxis.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.